| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Mrz―30 |
Cognitive Sequelae of COVID-19: Mechanistic Insights and Therapeutic Approaches |
Yu-Hao Chen, Jing-Shiun Jan, Chih-Hao Yang, Ting-Lin Yen, Tran Thanh Duy Linh, Saileela Annavajjula, et al. (+3) Mantosh Kumar Satapathy, Shin-Yi Tsao, Cheng-Ying Hsieh |
| 2 |
[GO] |
2024―Okt―11 |
Correction to “Reduced Risk Tolerance and Cortical Excitability Following COVID-19 Infection” |
|
| 3 |
[GO] |
2024―Aug―07 |
Reduced risk tolerance and cortical excitability following COVID-19 infection |
Yujing Wang, Haoran Yang, Chongzhi Wang, Ti-Fei Yuan, Song Zhang |
| 4 |
[GO] |
2024―Jun―26 |
Evidences of neurological injury caused by COVID-19 from glioma tissues and glioma organoids |
Huimin Hu, Chen Wang, Rui Tao, Bohan Liu, Dazhao Peng, Yankun Chen, Wei Zhang |
| 5 |
[GO] |
2023―Nov―30 |
Telemedicine during the COVID-19 epidemic improves outcomes in children with tuberous sclerosis complex: A 1206 visits retrospective cohort study |
Xia Wang, Ji Wang, Xiaonan Du, Lifei Yu, Yuanfeng Zhou, Shuizhen Zhou, et al. (+2) Yi Wang, Yifeng Ding |
| 6 |
[GO] |
2023―Jun―27 |
Cerebral venous thrombosis in patients with autoimmune disease, hematonosis or coronavirus disease 2019: Many familiar faces and some strangers |
Yifan Zhou, Huimin Jiang, Huimin Wei, Xuechun Xiao, Lu Liu, Xunming Ji, Chen Zhou |
| 7 |
[GO] |
2023―Mrz―09 |
Impact of the COVID-19 pandemic on acute stroke care: An analysis of the 24-month data from a comprehensive stroke center in Shanghai, China |
Qimin Hu, Yiming Hu, Yue Gu, Xiaoyan Song, Yijue Shen, Haiyan Lu, et al. (+6) Li Zhang, Peifeng Liu, Guodong Wang, Chunni Guo, Kan Fang, Qiaoshu Wang |
| 8 |
[GO] |
2022―Dez―07 |
Multiple sclerosis as a model to investigate
SARS-CoV
-2 effect on brain atrophy |
Michael Rebsamen, Christoph Friedli, Piotr Radojewski, Lara Diem, Andrew Chan, Roland Wiest, et al. (+3) Anke Salmen, Christian Rummel, Robert Hoepner |
| 9 |
[GO] |
2022―Apr―12 |
Is COVID-19 severity associated with reduction in T lymphocytes in anti-CD20-treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder? |
Robert Hoepner, Christian P Kamm, Christoph Friedli, Anke Salmen, Andrew Chan |
| 10 |
[GO] |
2021―Okt―09 |
Chronic long-COVID syndrome: A protracted COVID-19 illness with neurological dysfunctions |
Abdul Mannan Baig |
| 11 |
[GO] |
2021―Jun―16 |
Encephalopathy at admission predicts adverse outcomes in patients with SARS-CoV-2 infection |
Lei Tang, Shixin Liu, Yanhe Xiao, Thi My Linh Tran, Ji Whae Choi, Jing Wu, et al. (+16) Kasey Halsey, Raymond Y. Huang, Jerrold Boxerman, Sohil H Patel, David Kung, Renyu Liu, Michael D. Feldman, Daniel D Danoski, Wei-hua Liao, Scott E. Kasner, Tao Liu, Bo Xiao, Paul J. Zhang, Michael Reznik, Harrison X. Bai, Li Yang |
| 12 |
[GO] |
2021―Jan―16 |
Speech disturbance plays critical role in stroke recognition during COVID-19 pandemic |
Renyu Liu, Marc Fisher, Anthony Rudd, Jing Zhao |
| 13 |
[GO] |
2020―Okt―15 |
Slower recovery of outpatient clinics than inpatient services for stroke and other neurological diseases after COVID-19 Pandemic |
Jing Zhao, Yong Wang, Marc Fisher, Renyu Liu |
| 14 |
[GO] |
2020―Jul―29 |
The global impact of COVID-19 on acute stroke care |
Renyu Liu, Jing Zhao, Marc Fisher |
| 15 |
[GO] |
2020―Jul―17 |
COVID-19 and post-traumatic stress disorder: A vicious circle involving immunosuppression |
Xiao Liang, Yuncheng Zhu, Yiru Fang |
| 16 |
[GO] |
2020―Apr―08 |
Neurological manifestations in COVID-19 caused by SARS-CoV-2 |
Abdul Mannan Baig |
|
